Investors

Invest in 21st century rapid test technology

Our business model will evolve rapidly over the next 12 months. We are therefore open to talks with potential active or passive investors who have an affinity for our products. We look forward to meet you.

Write us an e-mail and we will get back to you immediately.

investors@convirmdx.com

Wiggenweg 3
9404 Rorschacherberg, Switzerland

Tel: +41 71 855 07 49
Mail: office@convirmdx.com

Convirm DX AG

The rapid test technology for the 21st century.

Reliability, speed and ease of use of antibody tests are key to minimizing risk and saving lives.